Regulatory T cells in control of the immune response to acute bacterial infection and sepsis
调节性 T 细胞控制对急性细菌感染和脓毒症的免疫反应
基本信息
- 批准号:G0700153/1
- 负责人:
- 金额:$ 54.48万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2007
- 资助国家:英国
- 起止时间:2007 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The immune system is evolved to mount a rapid, protective response against infection. At the same time, it is tightly regulated in order that this response does not overshoot so as to cause inflammatory damage. A key way in which such regulation comes about is through the action of a white blood cell population termed regulatory T cells, or Tregs. Relatively little work has previously been done on the role that Tregs might play in regulating the immune response in the context of severe bacterial infection. These infections can involve sepsis, the condition whereby there is an inflammatory response throughout the body, often leading to organ failure or, in the condition termed septic shock , rapid fall in blood pressure. Septic shock leads to death in 40-70% of cases. There is thus an urgent need to gain a better understanding of the immunological events leading to this condition and so design better medicines. A current view suggests that it might be the consequence of an exaggerated, damaging, immune response. Little work has been done on the role of Tregs in controlling this, though we have recently been doing work to find out. The patient needs to mount a rapid and effective immune response to infection, so might this involve some mechanism for taking the brakes off with respect to Treg control, yielding a bigger response? Alternatively, perhaps bacteria have evolved mechanisms to subvert the immune response, producing substances that are able to further enhance Treg function and constrain immunity. A third possibility is that a large amount of control by Tregs is indeed brought to bear, but this is an appropriate response to limit disease damage. We will address these possibilities in a well-defined transgenic mouse model of gram-positive sepsis. The work involves defining the Treg changes that occur at the site of infection and in the whole body after infecting with the gram-positive bacteria, Streptococcus pyogenes. We will then see what happens if the influence of Tregs is removed, either by giving an antibody or by doing the work in knockout mice. These studies should aid our fundamental understanding of Tregs during bacterial infection, as well as offering clues for future therapeutic manipulation of the immune response in septic shock.
免疫系统的进化是为了对感染产生快速的保护性反应。同时,它受到严格的调节,以便这种反应不会过度,从而导致炎症损伤。这种调节的一个关键途径是通过一种称为调节性T细胞(Tcl 2)的白色血细胞群的作用。相对较少的工作,以前已经做了的作用,THEOTH可能发挥调节免疫反应的背景下,严重的细菌感染。这些感染可能涉及脓毒症,即全身出现炎症反应的情况,通常导致器官衰竭,或者在称为脓毒性休克的情况下,血压迅速下降。感染性休克导致40-70%的病例死亡。因此,迫切需要更好地了解导致这种情况的免疫学事件,从而设计更好的药物。目前的观点认为,这可能是一种夸大的、破坏性的免疫反应的结果。虽然我们最近一直在做研究,但关于TdR在控制这一过程中的作用的研究很少。病人需要对感染产生快速有效的免疫反应,那么这是否涉及某种机制,可以解除Treg控制的刹车,产生更大的反应?或者,也许细菌已经进化出破坏免疫反应的机制,产生能够进一步增强Treg功能和抑制免疫的物质。第三种可能性是,Tactus确实进行了大量的控制,但这是限制疾病损害的适当反应。我们将在明确的革兰氏阳性脓毒症转基因小鼠模型中解决这些可能性。这项工作涉及定义感染部位和感染革兰氏阳性细菌化脓性链球菌后全身发生的Treg变化。然后,我们将看到,如果通过给予抗体或在基因敲除小鼠中进行这项工作,消除了TdR的影响,会发生什么。这些研究有助于我们对细菌感染过程中THBE的基本理解,并为未来脓毒性休克免疫反应的治疗操作提供线索。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Altmann其他文献
Expandir nosso entendimento da síndrome pós-COVID-19. Relatório de um webinar da OMS. 9 de fevereiro de 2021
展开 OMS 网络研讨会的相关问题。
- DOI:
10.37774/9789275723999 - 发表时间:
2021 - 期刊:
- 影响因子:2.6
- 作者:
Dra . Andrea Lerner;Sharon Saydah;Dr . Ettore Beghi;Daniel Altmann;Dr . Jose Luis Ayuso;Carlos Pardo;Dr. Tarun Dua;Dra. Carine Alsokhn Dr;Fahmy Hanna Dr;Robert Jakob Dr;Jacobus Preller Dr;Pryanka Relan;Professor John Marshall;Professora Djillali;Annane;Nigel Curtis;Dra . Anne;Gottberg;Professora Beverley;Hunt - 通讯作者:
Hunt
Patient Information in Radiooncology
- DOI:
10.1007/s00066-002-0969-9 - 发表时间:
2002-10-01 - 期刊:
- 影响因子:2.500
- 作者:
Christof Schäfer;Barbara Dietl;Kurt Putnik;Daniel Altmann;Jörg Marienhagen;Manfred Herbst - 通讯作者:
Manfred Herbst
Role of the adhesion molecule ICAM‐1 (CD54) in staphylococcal enterotoxin‐mediated cytotoxicity
粘附分子 ICAM-1 (CD54) 在葡萄球菌肠毒素介导的细胞毒性中的作用
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:5.4
- 作者:
M. Dohlsten;G. Hedlund;P. Lando;J. Trowsdale;Daniel Altmann;M. Patarroyo;H. Fischer;T. Kalland - 通讯作者:
T. Kalland
Bone mineral density in institutionalised patients with refractory epilepsy
- DOI:
10.1016/j.seizure.2007.03.003 - 发表时间:
2007-09-01 - 期刊:
- 影响因子:
- 作者:
Josephine Swanton;Robert Simister;Daniel Altmann;Hilary Watts;Richard Keen;John S. Duncan;Matthias J. Koepp - 通讯作者:
Matthias J. Koepp
Daniel Altmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Altmann', 18)}}的其他基金
'REBRACOVID' - multicentre cohort study of the natural history and immunology of COVID-19 in Brazil
“REBRACOVID”——巴西 COVID-19 自然史和免疫学的多中心队列研究
- 批准号:
MR/V036939/1 - 财政年份:2020
- 资助金额:
$ 54.48万 - 项目类别:
Research Grant
Immunological tools for a seroprevalence and immune status map of Burkholderia pseudomallei and thailandensis in Vietnam
越南鼻疽伯克霍尔德菌和泰国鼻疽的血清阳性率和免疫状态图的免疫学工具
- 批准号:
MR/R02622X/1 - 财政年份:2020
- 资助金额:
$ 54.48万 - 项目类别:
Research Grant
'SPIICA' - the Sao Paulo-Imperial College Immune Correlates in Arbovirus Infection Network
“SPIICA”——圣保罗帝国学院与虫媒病毒感染网络的免疫相关性
- 批准号:
MR/S019553/1 - 财政年份:2019
- 资助金额:
$ 54.48万 - 项目类别:
Research Grant
Zika: CD4 T cell immune correlates of Zika virus exposure
寨卡病毒:CD4 T 细胞免疫与寨卡病毒暴露相关
- 批准号:
MC_PC_15106 - 财政年份:2016
- 资助金额:
$ 54.48万 - 项目类别:
Intramural
Cellular and transcriptomic analysis of regulatory T cells in streptococcal infection
链球菌感染中调节性 T 细胞的细胞和转录组分析
- 批准号:
G0901386/1 - 财政年份:2010
- 资助金额:
$ 54.48万 - 项目类别:
Research Grant
相似国自然基金
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
- 批准号:82371634
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
- 批准号:82371801
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
脐带间充质干细胞微囊联合低能量冲击波治疗神经损伤性ED的机制研究
- 批准号:82371631
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
- 批准号:82371379
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
- 批准号:82370751
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
视网膜色素上皮细胞中YAP/mtDNA/cGAS-炎症小体轴在干性年龄相关性黄斑变性中的作用
- 批准号:82371073
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TRIM25-PHGDH信号轴调控脓毒症肺上皮细胞铁死亡的机制研究
- 批准号:82372151
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
CD8+T细胞亚群在抗MDA5抗体阳性皮肌炎中的致病机制研究
- 批准号:82371805
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
- 批准号:82370981
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Gene regulatory network control of olfactory cortex cell type specification
嗅觉皮层细胞类型规范的基因调控网络控制
- 批准号:
10656692 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Intestinal Microbiota Affect Stroke Outcome by Modulating the Dendritic Cell-regulatory T Cell Axis
肠道微生物群通过调节树突状细胞调节 T 细胞轴影响中风结果
- 批准号:
10751249 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Investigating the Regulatory Roles of Histone Chaperones in Cellular Plasticity
研究组蛋白伴侣在细胞可塑性中的调节作用
- 批准号:
10714076 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Cis regulatory control of avian bill morphogenesis
禽喙形态发生的顺式调控
- 批准号:
10756238 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Regulatory Mechanisms Linking Spatial Gene Control and Genome Organization
连接空间基因控制和基因组组织的调控机制
- 批准号:
10712390 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Leveraging ubiquitin-dependent regulatory mechanisms to improve proteome quality in health and disease
利用泛素依赖性调节机制提高健康和疾病中的蛋白质组质量
- 批准号:
10552479 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
滤泡调节性 T 细胞作为癌症免疫治疗新细胞靶点的评估
- 批准号:
10737557 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Novel regulatory mechanisms controlling hepatic apoB-Lp lipid loading and secretion
控制肝脏apoB-Lp脂质负荷和分泌的新调控机制
- 批准号:
10628991 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
Function of NLRP3 in regulatory T cell-mediated control of intestinal homeostasis
NLRP3 在调节性 T 细胞介导的肠道稳态控制中的功能
- 批准号:
10748891 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别:
The dissection of non-canonical cis-regulatory elements downstream of beta-globin locus in the fetal hemoglobin gene regulation
胎儿血红蛋白基因调控中β-珠蛋白位点下游非典型顺式调控元件的剖析
- 批准号:
10718028 - 财政年份:2023
- 资助金额:
$ 54.48万 - 项目类别: